ANIK R&D to Revenue
Anika Therapeutics Inc · R&D to Revenue
ANIK R&D to Revenue
Latest reported22.84%period ending
ANIK FY R&D/Revenue (0.00% → 22.84%)
Latest values, visible window
High-resolution chart · PNG
ANIK r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 22.8419% | |
| 21.3032% | |
| 18.0169% | |
| 16.0955% | |
| 18.4899% | |
| 17.9607% | |
| 14.5406% | |
| 17.2327% | |
| 16.5641% | |
| 10.3812% | |
| 9.6635% | |
| 7.7126% | |
| 9.403% | |
| 7.5507% | |
| 9.5231% | |
| 12.3741% | |
| 20.3847% | |
| 20.6794% | |
| 14.1571% | |
| 13.4737% | |
| 15.8572% | |
| 15.4425% | |
| 16.8463% | |
| 29.7851% | |
| 37.8407% | |
| 19.9568% | |
| 31.1111% | |
| 14.3885% | |
| 16.6667% | |
| 0% | |
| 38.2353% | |
| 31.9149% | |
| 0% |